Cardiovascular drugs in Latin America

Cardiovascular Drugs Market Overview

Geographical Scope:
Countries
Brazil
Andean Region (Colombia and Venezuela)
Antihypertensives
Segmentation Antidyslipidemics
Others
•Cardiovascular disease (CVD) is the main cause of disability and premature death
throughout the world.
•Latin America lifestyle is leading its population to achieve high percentages of
cardiovascular diseases prevalence (20% - 30%).
•Total Latin American Cardiovascular Drugs market for 2006 was US$1,502 million and is
expected to increase to US$3,309 million by 2011.

Market Size
Cardiovascular Drugs Market: Revenue Forecasts
(Latin America) 2006 - 2011

Where is the market heading?

Market Drivers and Restraints